Patrick Elder

1.3k citations

71 papers · 768 indexed · h-index 17

Hematology top 2%
- Hematopoietic Stem Cell Transplantation 22
- Acute Myeloid Leukemia Research 15
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 7
Transplantation top 10%
Genetics top 10%
- Chronic Lymphocytic Leukemia Research 6
Oncology top 10%
Immunology
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 10
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 8
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 5

Co-authors: Sam Penza Steven M. Devine Thomas S. Lin William Blum Don M. Benson Craig C. Hofmeister Guido Marcucci Belinda R. Avalos
Cited by: Hematology Transplantation Genetics
Journals: Blood (13 papers)Biology of Blood and Marrow Transplantation (9 papers)Bone Marrow Transplantation (6 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Patrick Elder

67 papers receiving 751 citations

Peers

Countries citing papers authored by Patrick Elder

Since Specialization

Citations

This map shows the geographic impact of Patrick Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Elder more than expected).

Fields of papers citing papers by Patrick Elder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Elder. The network helps show where Patrick Elder may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick Elder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Elder Line = papers co-authored together Patrick Elder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Incidence of Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Is Not Lowered By Reduction of Acute GvHD (aGvHD) in Patients Receiving Post-Transplant Cyclophosphamide (PTCy) GvHD Prophylaxis: A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy ·Theresa Hahn,Qiuhong Zhao,Т.Г. Нефедова,Patrick Elder,Goh Shundoh,Stella M. Davies,Nelli Bejanyan,Sumithira Vasu	2025	1
2	Impact of chronic graft- versus -host disease on non-relapse mortality and survival Leukemia & lymphoma ·Justin Jiang,Audrey M. Sigmund,Qiuhong Zhao,Patrick Elder,Sumithira Vasu,Samantha Jaglowski,Alice S. Mims,Hannah Choe,Karilyn Larkin,Sarah Wall,Nicole R. Grieselhuber,Basem M. William,Sam Penza,Don M. Benson,Yvonne A. Efebera,Nidhi Sharma	2024	1
3	Survival outcomes following autologous stem cell transplant with melphalan 140mg/m ² versus 200mg/m ² preparative regimens in patients with multiple myeloma Leukemia & lymphoma ·Nidhi Sharma,L. Perez,Qiuhong Zhao,Christopher E. Hardy,Francesca Cottini,Patrick Elder,Ashley Rosko,Naresh Bumma,Abdullah Khan,Elvira Umyarova,Srinivas Devarakonda,Yvonne A. Efebera,Don M. Benson	2023	0
4	Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy Frontiers in Oncology ·Maja Vlahović,Ying Huang,Neeta Goel,Patrick Elder,Alice S. Mims,Sarah Wall	2022	2
5	Outcomes of Large B-Cell Lymphoma Patients By Post CAR-T Salvage Regimen at a Single Institution Blood ·Audrey M. Sigmund,Nathan Denlinger,منى طارق حامد الجناينى,Patrick Elder,David A. Bond,Jonathan E. Brammer,Ayman Saad,Sam Penza,Carlos Zamorano Millán,Samantha Jaglowski,Adam S. Kittai	2021	2
6	Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS Leukemia & lymphoma ·Àngels Miquel Vilanova,Хомус Сайдаара Саарын Кыыьа,Qiuhong Zhao,Patrick Elder,Jonathan E. Brammer,Karilyn Larkin,Samantha Jaglowski,Alice S. Mims,Sam Penza,Sumithira Vasu,Sarah Wall,Basem M. William,Ayman Saad,Julianna Roddy,Hannah Choe,Seth R. Siegel	2020	5
7	Surgical Management of Primary Bone Lymphoma of the Hip: A Case Report and Review of the Literature SHILAP Revista de lepidopterología ·Grace Kennedy,Umar Bausir,Kevin Johnston,Patrick Elder	2019	4
8	Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT) A. I. Kuklin,Lai Wei,Luís Bustamante,Patrick Elder,William W. Falk,Е. Г. Чернов,Ashley Rosko,Don M. Benson,Steven M. Devine,Craig C. Hofmeister,Yvonne A. Efebera	2019	0
9	Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case–control study Bone Marrow Transplantation ·Firda Tri Setia,Maryam B. Lustberg,Steven M. Devine,Patrick Elder,Leslie A. Andritsos,Ruediger Lengmueller	2013	10
10	Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma Leukemia & lymphoma ·Neil Dunavin,Lai Wei,Patrick Elder,Gary Phillips,Don M. Benson,Craig C. Hofmeister,Sam Penza,Carli N Greenfield,Zheng Ying,Simon Elder,Renming Li,Volker Mogel,Nyla A. Heerema,John C. Byrd,Steven M. Devine,Yvonne A. Efebera	2012	52
11	Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan‐based reduced toxicity conditioning Hematological Oncology ·Mehdi Hamadani,Michael Craig,Gary Phillips,Jame Abraham,William Tse,Aaron Cumpston,Laura F. Gibson,Scot C. Remick,Hsieh Ming-Hsien,Candra Aditama,Patrick Elder,Craig C. Hofmeister,Sam Penza,Yvonne A. Efebera,Leslie A. Andritsos,Ramiro Garzon,Don M. Benson,William Blum,Steven M. Devine	2011	11
12	Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia Bone Marrow Transplantation ·Anuj Mahindra,Brian J. Bolwell,Lisa Rybicki,Patrick Elder,M Kalaycio,Robert M. Dean,Jim Nelson,Ronald Sobecks,Shawnda Tench,S Andresen,Brad Pohlman,John Sweetenham,Steven M. Devine,Edward A. Copelan	2011	22
13	Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia British Journal of Haematology ·Shubham Pant,Mehdi Hamadani,Anthony J. Dodds,Jeff Szer,Pamela Crilley,V. N. Mamin,Gary Phillips,Patrick Elder,Ian Nivison‐Smith,Belinda R. Avalos,Sam Penza,David Topolsky,Ronald Sobecks,Matt Kalaycio,Brian J. Bolwell,Edward A. Copelan	2009	2
14	Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies Biology of Blood and Marrow Transplantation ·Mehdi Hamadani,William Blum,Gary Phillips,Patrick Elder,Leslie A. Andritsos,Craig C. Hofmeister,Lynn O’Donnell,Rebecca B. Klisovic,Sam Penza,Ramiro Garzon,Patrick Chaing,Thomas S. Lin,M. Shabani Mahalli,Don M. Benson,John C. Byrd,Guido Marcucci,Steven M. Devine	2009	70
15	Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas Biology of Blood and Marrow Transplantation ·Mehdi Hamadani,Don M. Benson,Craig C. Hofmeister,Patrick Elder,William Blum,Pierluigi Porcu,Ramiro Garzon,Kristie A. Blum,Thomas S. Lin,Guido Marcucci,Steven M. Devine	2009	31
16	Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation Biology of Blood and Marrow Transplantation ·Mehdi Hamadani,Craig C. Hofmeister,Andi Sitti Halimah,Gary Phillips,Patrick Elder,William Blum,Sam Penza,Thomas S. Lin,Rebecca B. Klisovic,Guido Marcucci,Sherif S. Farag,Steven M. Devine	2008	49
17	High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma Leukemia Research ·Don M. Benson,Patrick Elder,Thomas S. Lin,William Blum,Sam Penza,Belinda R. Avalos,E. A. Copelan,Sherif S. Farag	2006	24
18	Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·P. Sulem,Sherif S. Farag,Brian J. Bolwell,Patrick Elder,Sam Penza,Matt Kalaycio,Belinda R. Avalos,Brad Pohlman,Guido Marcucci,Ronald Sobecks,Thomas S. Lin,Steven Andrèsen,Edward A. Copelan	2006	27
19	High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation Biology of Blood and Marrow Transplantation ·William Blum,Brian J. Bolwell,Gary Phillips,Sherif S. Farag,Thomas S. Lin,Belinda R. Avalos,Sam Penza,Guido Marcucci,John C. Byrd,Matt Kalaycio,Ronald Sobecks,Brad Pohlman,Stacey Brown,Patrick Elder,Edward A. Copelan	2006	16
20	Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged ≥50 years compared to younger adults with low-risk disease Bone Marrow Transplantation ·Sherif S. Farag,Patrick Elder,Guido Marcucci,Sam Penza,Ewa Mrózek,A Molina,Thomas S. Lin,Belinda R. Avalos,Edward A. Copelan	2003	9

About Patrick Elder

Patrick Elder is a scholar working on Hematology, Transplantation, Genetics, Oncology and Pathology and Forensic Medicine, having authored 71 papers that have together received 768 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (15 papers), Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). The work is most often cited by research in Hematology (380 citations), Transplantation (31 citations), Genetics (109 citations), Oncology (237 citations) and Immunology (166 citations). Patrick Elder has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Sam Penza, Steven M. Devine, Thomas S. Lin, William Blum, Don M. Benson, Craig C. Hofmeister, Guido Marcucci, Belinda R. Avalos, Gary Phillips and John C. Byrd. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Transplantation and Cellular Therapy and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact